Arthritis drug cuts deaths in hospitalized Covid-19 patients, major study shows

(By Matthew Herper for STAT)

Tocilizumab, a drug usually used to treat rheumatoid arthritis, reduced the rate for death in Covid-19 patients, according to a major clinical trial.  Continue reading the article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org